To see the other types of publications on this topic, follow the link: Chronic myeloid leukemia (CML).

Books on the topic 'Chronic myeloid leukemia (CML)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 42 books for your research on the topic 'Chronic myeloid leukemia (CML).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Li, Shaoguang, and Haojian Zhang, eds. Chronic Myeloid Leukemia. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-4011-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hehlmann, Rüdiger, ed. Chronic Myeloid Leukemia. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-33198-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hehlmann, Rüdiger, ed. Chronic Myeloid Leukemia. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-71913-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Estella, Matutes, ed. Chronic myeloid leukaemias. Oxford: Clinical Pub., 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hughes, Timothy P., David M. Ross, and Junia V. Melo. Handbook of Chronic Myeloid Leukemia. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-08350-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Saglio, Giuseppe, and Carmen Fava. The Treatment of Chronic Myeloid Leukemia. Unitec House, 2 Albert Place, London N3 1QB, UK: Future Medicine Ltd, 2013. http://dx.doi.org/10.2217/9781780842738.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

National Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London: National Institute for Clinical Excellence, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

National Institute for Clinical Excellence. Guidance on the use of imatinib for chronic myeloid leukaemia. London: National Institute for Clinical Excellence, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Aswald, Jorg M. Intracellular cytokine analysis in T-cells of patients with chronic myeloid leukemia. Ottawa: National Library of Canada, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ramahi, Tarik Mustafa. The rearrangement of the immunoglobulin and T-cell receptor genes in chronic myelogenous leukemia /by Tarik Mustafa Ramahi. [New Haven: s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Weinberg, Robert A. (Robert Allan), 1942-, ed. The Philadelphia chromosome: A mutant gene and the quest to cure cancer at the genetic level. New York: The Experiment, LLC, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Mathieson, Alister Mark. Selective cytotoxicity of gammadelta T cells for chronic myeloid leukemia (CML). 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Steensma, David P. Malignant Hematology. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0296.

Full text
Abstract:
The hematologic neoplasms include lymphoproliferative disorders (eg, chronic lymphocytic leukemia [CLL]/small lymphocytic lymphoma [SLL], large granular lymphocyte leukemia, hairy cell leukemia [HCL], Hodgkin lymphoma, non-Hodgkin lymphoma), plasma cell disorders (multiple myeloma, light chain amyloidosis, Waldenström macroglobulinemia, POEMS syndrome, heavy chain disease, plasmacytoma), chronic myeloid neoplasms (chronic myeloid leukemia, the BCR/ABL-negative myeloproliferative neoplasms, myelodysplastic syndromes), and acute leukemia (acute myeloid leukemia, acute lymphocytic leukemia). In addition, clonal but not overtly malignant conditions are common in the general population, including monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B lymphocytosis (MBL).
APA, Harvard, Vancouver, ISO, and other styles
14

(Editor), Jorge Cortes, and Michael Deininger (Editor), eds. Chronic Myeloid Leukemia. Informa Healthcare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Hehlmann, Rüdiger. Chronic Myeloid Leukemia. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

E, Cortés F. Jorge, and Deininger Michael, eds. Chronic myeloid leukemia. New York: Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Chronic Myeloid Leukemia. London: Taylor & Francis Group Plc, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Mughal, Tariq I., ed. Chronic Myeloid Leukemia. Informa Healthcare, 2013. http://dx.doi.org/10.3109/9781842145784.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Cortes, Jorge, and Michael Deininger, eds. Chronic Myeloid Leukemia. CRC Press, 2006. http://dx.doi.org/10.3109/9780849379567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Mughal, Tariq I. Chronic Myeloid Leukemia. CRC Press, 2013. http://dx.doi.org/10.1201/b15119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Hughes, Timothy P. P., David M. Ross, and Junia V. Melo. Handbook of Chronic Myeloid Leukemia. Adis, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Chronic Myeloid Leukemia: Biology and Treatment. Informa Healthcare, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Chronic Myeloid Leukemia: Methods and Protocols. Humana, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

1947-, Talpaz Moshe, and Kantarjian Hagop 1952-, eds. Medical management of chronic myelogenous leukemia. New York: Dekker, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

(Editor), Moshe Talpaz, and Hagop Kantarjian (Editor), eds. Medical Management of Chronic Myelogenous Leukemia (Basic and Clinical Oncology , Vol 16). Informa Healthcare, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Popat, Uday R., and Celalettin Ustun. Chronic Myeloid Leukemia: From Daily Management to Complicated Issues. Nova Science Publishers, Incorporated, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Chronic Myeloid Leukemia: A Handbook for Hematologists and Oncologists. Taylor & Francis Group, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Myeloid leukemia: Methods and protocols. Totowa, NJ: Humana Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Harry, Iland, Hertzberg Mark, and Marlton Paula, eds. Myeloid leukemia: Methods and protocols. Totowa, N.J: Humana Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

M, Carella Angelo, ed. Chronic myeloid leukaemia: Biology and treatment. London: Martin Dunitz, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

1941-, Deisseroth Albert B., and Arlinghaus Ralph B, eds. Chronic myelogenous leukemia: Molecular approaches to research and therapy. New York: Dekker, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

(Editor), Harry Iland, Mark Hertzberg (Editor), and Paula Marlton (Editor), eds. Myeloid Leukemia: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

(Editor), Tariq Mughal, and John M. Goldman (Editor), eds. Chronic Myeloproliferative Disorders. Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Chronic Myeloid Neoplasias And Clonal Overlap Syndromes Epidemiology Pathophysiology And Treatment Options. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Ajithkumar, Thankamma, Ann Barrett, Helen Hatcher, and Natalie Cook. Paediatric malignancies. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199235636.003.0015.

Full text
Abstract:
Leukaemia is the commonest cancer (accounting for >40% of cases) in children. It is a clonal proliferation of stem cells which leads to bone marrow failure and tissue infiltration.• Acute lymphoblastic leukaemia (ALL): 4/100,000• Acute myeloid leukaemia (AML): 0.7/100,000• Chronic myeloid leukaemia (CML): 0.2/100,000...
APA, Harvard, Vancouver, ISO, and other styles
36

Provan, Drew, Trevor Baglin, Inderjeet Dokal, and Johannes de Vos. Leukaemia. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0004.

Full text
Abstract:
Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)
APA, Harvard, Vancouver, ISO, and other styles
37

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos, and Hassan Al-Sader. Leukaemia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0004_update_001.

Full text
Abstract:
Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)
APA, Harvard, Vancouver, ISO, and other styles
38

Turley, Stefanie A. Functional characterization of PRDM12, a gene recurrently deleted during t(9;22) rearrangements in chronic myeloid leukemia patients. 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa, and Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

Full text
Abstract:
The 2001 World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms categorized “the leukemias” into two major groupings—myeloid and lymphoid. Myeloid neoplasms, which are the primary focus of this chapter, include acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Lymphoid neoplasms are mostly reviewed as part of non-Hodgkin lymphoma in Chapter 40 of this volume, although descriptive patterns and selected etiologic studies are briefly discussed in this chapter because of historical trends. Worldwide, leukemias are ranked eleventh among all cancer types, comprising approximately 2.5% of all malignancies. Exposure to ionizing radiation and certain chemical carcinogens (e.g., cytotoxic chemotherapy, benzene, formaldehyde) are the most consistently associated risk factors for MDS and/or AML. Radiation has been linked with CML, and cigarette smoking with AML. Fewer risk factors have been identified for MPNs. Some evidence implicates increased risks of AML in rubber workers, farmers, and other agricultural workers.
APA, Harvard, Vancouver, ISO, and other styles
40

Culture, characterization, and cytotoxic activity of [gamma][delta] Tcells from patients with Ph(+) chronic myeloid leukemia: A potential role in cell therapy. Ottawa: National Library of Canada, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Weinberg, Robert A., and Jessica Wapner. Philadelphia Chromosome: A Genetic Mystery, a Lethal Cancer, and the Improbable Invention of a Lifesaving Treatment. Experiment LLC, The, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Mughal, Tariq I., and Tiziano Barbui, eds. Oxford Specialist Handbook: Myeloproliferative Neoplasms. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198744214.001.0001.

Full text
Abstract:
Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades. Even more importantly is the speed at which many of these findings were translated to accord survival benefits to our patients with MPN, in particular chronic myeloid leukaemia (CML), polycythaemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF). This text offers a detailed evidence-based guide to MPN in an easily accessible format, structure to facilitate learning specialist information presenting core information in ‘bite size’ chunks. Each chapter summarizes the state-of-the art preclinical and clinical knowledge, and its impact on the clinical management of patients with MPN.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography